Standardization of prostate-specific antigen assays: Impact on reference intervals and clinical decision thresholds.
BackgroundProstate-specific antigen (PSA) remains the most widely used biomarker for prostate cancer screening, diagnosis, and monitoring. However, despite decades of standardization efforts, significant inter-assay variability persists, with important consequences for clinical interpretation and decision-making.Object...